NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Revolutionizing Depression Treatment: Dash TMS Protocol for Short Treatment
Embark on a journey into the future of depression treatment with the groundbreaking study featured in "Brain Stimulation." This research, [...]
TMS Breakthrough: Elevate Your Mood in a Matter of Days!
Embark on a transformative journey with Accelerated Transcranial Magnetic Stimulation (aTMS), a revolutionary therapy designed to expedite recovery for various [...]
Unlocking the Power of Transcranial Magnetic Stimulation (TMS): Insights from Dr. Khademi’s Workshop at Beth Israel Medical Center
Unveiling the Future: Dr. Khademi's Workshop Sheds Light on TMS Revolution In a groundbreaking workshop at Beth Israel Medical Center, [...]
Empowering Recovery: The Role of Neuromodulation in Spinal Cord Injury Rehabilitation
In a groundbreaking study by Nicholas D James, Stephen B McMahon, Edelle C Field-Fote, and Elizabeth J Bradbury, the transformative [...]
Transcranial Magnetic Stimulation for Alcohol Craving: A Breakthrough Study
This study explores the anticraving efficacy of high-frequency repetitive transcranial magnetic stimulation (rTMS) on the right and left dorsolateral prefrontal [...]
Revolutionizing Spinal Cord Injury Recovery: The Impact of Transcranial Magnetic Brain Stimulation
In a pioneering study conducted at the National Spinal Injuries Centre and Division of Neuroscience, researchers investigated the potential of [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social